Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on February 12, 2008
JNCI Journal of the National Cancer Institute 2008 100(4):230-231; doi:10.1093/jnci/djn015
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/4/230    most recent
djn015v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Giordano, S. H.
Right arrow Articles by Hortobagyi, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordano, S. H.
Right arrow Articles by Hortobagyi, G. N.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

EDITORIALS

Time to Remove the Subspecialty Blinders: Breast Cancer Does Not Exist in Isolation

Sharon H. Giordano, Gabriel N. Hortobagyi

Affiliation of authors: Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Correspondence to: Sharon Giordano, MD, MPH, Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe, Box 1354, Houston, TX 77030-4009 (e-mail: sgiordan@mdanderson.org).

The first 10% of the full text of this article appears below.

As oncologists, we focus on treating cancer and preventing cancer-related deaths. However, how aggressively are our patients treated for non–cancer-related medical problems? This question should be of great importance to oncologists, particularly those who treat breast cancer patients. The survival rates for breast cancer have improved over the past several decades, likely because of an increase in screening and improvements in therapy (1,2). As deaths from breast cancer fall and the population ages, breast cancer patients are increasingly likely to die of other illnesses. Thus, appropriate treatment of medical conditions other than breast cancer is critical for our patients’ overall health. Understanding the risk of death from breast cancer . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer
Judith-Anne W. Chapman, Daniel Meng, Lois Shepherd, Wendy Parulekar, James N. Ingle, Hyman B. Muss, Michael Palmer, Changhong Yu, and Paul E. Goss
J Natl Cancer Inst 2008 100: 252-260. [Abstract] [Full Text] [PDF]

IN THIS ISSUE
J Natl Cancer Inst 2008 100: 227. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JCOHome page
W. F. Anderson, I. Jatoi, and M. E. Sherman
Qualitative Age Interactions in Breast Cancer Studies: Mind the Gap
J. Clin. Oncol., November 10, 2009; 27(32): 5308 - 5311.
[Full Text] [PDF]

Home page
 Ann OncolHome page
C. Bouchardy, E. Rapiti, M. Usel, S. B. Majno, G. Vlastos, S. Benhamou, R. Miralbell, I. Neyroud-Caspar, H. M. Verkooijen, and V. Vinh-Hung
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors
Ann. Onc., August 24, 2009; (2009) mdp341v1.
[Abstract] [Full Text] [PDF]